KSBB Journal

The Korean Society for Biotechnology and Bioengineering (한국생물공학회)
권호 표지

Metronidazole Reduced Ammonia Toxicity in Human Hep G2 cell and Rat Hepatocytes

Hep G2 세포와 rat 간세포에서 Metronidazole에 의한 암모니아 독성 감소

  • Kim, Bo-Ae (Department of Biochemistry, Kyungpook National University) ;
  • Kim, Hyun-Jung (Department of Optometry, Konyang University) ;
  • Kim, You-Young (Department of Biochemistry, Kyungpook National University)
  • 김보애 (경북대학교 자연과학대학 생화학과) ;
  • 김현정 (건양대학교 안경광학과) ;
  • 김유영 (경북대학교 자연과학대학 생화학과)
  • Published : 2008.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Lipophilic ammonia is toxic gas and can easily diffuse across cell membranes. Excess ammonia is implicated in the pathogenesis of several metabolic disorders including hepatic encephalopathy and may result in the death. The purpose of this study was to clarify the inhibition effect of metronidazole on liver cell damage due to ammonia in human Hep G2 cell and rat hepatocytes. The effects of metronidazole were studied in ammonium chloride treated human Hep G2 cell (75 mM) and rat hepatocyte (100 mM) following $0.1{\mu}M$ metronidazole treatment. In MTZ+AC group, cell viabilities increased prominently and LDH activities decreased over 25% than AC group. Furthermore, ammonia level according to ammonium chloride treatment reduced over 30% and lipid peroxidation as an index of cell membrane damage decreased more than twice. By comparison with control, catalase activity showed more than 30% reduction in AC group while less than 10% reduction in MTZ+AC group, respectively. In addition, MTZ+AC group showed the similar cell structure as control in cell morphology study by using light microscope, and represented fluorescent intensity decrement compared with AC group in fluorescent microscopic study with avidin-TRITC fluorescent dye. And cleaved PARP expression due to ammonia reduced twofold or more in MTZ+AC group. As the results suggest, metronidazole may protect the liver cell by inhibiting cell damages due to ammonia and be used for an effective antagonist of ammonia in hyperammonemia.

본 연구에서는 암모니아에 의해 손상된 사람의 간세포주 Hep G2 cell과 rat의 hepatocyte에 대하여 metronidazole이 간 세포 손상을 억제하는 효과가 있음을 밝혔다. Metronidazole은 암모니아에 의한 세포 생존율 감소, 배지내의 암모니아 수준 및 지질과산화 증가 및 항산화 효소 발현 감소 그리고 세포 내 DNA 손상과 세포사멸을 억제하였다. 따라서 metronidazole은 암모니아로부터 기인하는 세포손상을 감소시켜 간세포 기능을 보호함으로써 간 기능의 저하로 발생한 과암모니아혈증에 효과적인 치료제로서의 가능성을 시사한다.

Keywords

References

  1. Sweeney, G. D., K. G. Jones, and F. Krestynski (1978), Effects of phenobarbital and 3-methylcholanthrene pretreatment on size, sedimentation velocity, and mixed function oxygenase activity of rat hepatocytes, J. Lab. Clin. Med. 91(3), 444-454
  2. Gaub, J., L. Fauerholdt, S. Keiding, J. Kondrup, P. Petersen, and G. L. Wantzin (1981), Cytophotometry of liver cells from ethanol fed rats: ethanol causes increased polyploidization and protein accumulation, Eur. J. Clin. Invest. 11(3), 235-237 https://doi.org/10.1111/j.1365-2362.1981.tb01846.x
  3. Endemann, G., P. G. Goetz, J. Edmond, and H. Brunengraber (1982), Lipogenesis from ketone bodies in the isolated perfused rat liver. Evidence for the cytosolic activation of acetoacetate, J. Biol. Chem. 257(7), 3434-3440
  4. Butterworth, R. F. (2002), Glutamate transporters in hyperammonemia, Neurochem. Int. 41(2-3), 81-85 https://doi.org/10.1016/S0197-0186(02)00027-X
  5. Bachmann, C., O. Braissant, A. M. Villard, O. Boulat, and H. Henry (2004), Ammonia toxicity to the brain and creatine, Mol. Genet. Metab. 81, S52-S57
  6. Ott, P. and F. S. Larsen (2004), Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal, Neurochem. Int. 44(4), 185-198 https://doi.org/10.1016/S0197-0186(03)00153-0
  7. Haussinger, D., F. Schliess, and G. Kircheis (2002), Pathogenesis of hepatic encephalopathy, J. Gastroenterol. Hepatol. 17(3), S256-S259 https://doi.org/10.1046/j.1440-1746.17.s3.10.x
  8. Morgan, M. Y. and K. E. Hawley (1987), Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial, Hepatology 7(6), 1278-1284 https://doi.org/10.1002/hep.1840070617
  9. Gill, M. A. and W. R. Kirchain (1996), Alcoholic liver disease in Pharmacotherapy: a phathophysiologic approach, 3rd ed., p785-800, Appleton & Lange Press, New York
  10. Watanabe, A., T. Sakai, S. Sato, F. Imai, M. Ohto, Y. Arakawa, and G. Toda (1997), Clinical Efficacy of Lactulose in Cirrhotic Patients With and Without Subclinical Hepatic Encephalopathy, Hepatology 26(6), 1410-1414 https://doi.org/10.1002/hep.510260606
  11. Blei, A. T. and J. Córdoba (2001), Hepatic encephalopathy, Am. J. Gastroenterol. 96(7), 1968-1976 https://doi.org/10.1111/j.1572-0241.2001.03964.x
  12. Wood, S., C. M. Kennedy, and R. P. Galask (2007), Prolonged vaginalis: a case report, J. Roprod. Med. 52(11), 1057-1058
  13. Gupta, A. K. and M. Chaudhry (2002), Topical Metronidazole for Rosacea, Skin Therapy Lett. 7(1), 1-3
  14. Choi, Y. S., D. Y. Lee, I. Y. Kim, S. Kang, K. Ahn, H. J. Kim, Y. H. Jeong, G. T. Chun, J. K. Park, and I. H. Kim (2000), Ammonia removal using hepatoma cells in mammalian cell cultures, Biotechnol. Prog. 16(5), 760-768 https://doi.org/10.1021/bp000099d
  15. Beers, R. F. Jr. and I. W. Sizer (1952), A spectrophotometric methods for measuring the breakdown of hydrogen peroxides by catalase, J. Biol. Chem. 195(1), 133-135
  16. Struthers, L., R. Patel, J. Clark, and S. Thomas (1998), Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues, Anal. Biochem. 255(1), 20-31 https://doi.org/10.1006/abio.1997.2354
  17. Kim, K. M., J. J. Song, J. Y. An, Y. T. Kwon, and Y. J. Lee (2005), Pretreatment of Acetylsalicylic Acid Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis by Down-regulating BCL-2 Gene Expression, J. Biol. Chem. 280(49), 41047-41056 https://doi.org/10.1074/jbc.M503713200
  18. Yurdaydin, C., T. J. Walsh, H. D. Engler, J. H. Ha, Y. Li, E. A. Jones, and A. S. Basile (1995), Gut bacteria provide precursors of benzodiazepine receptor ligands in a rat model of hepatic encephalopathy, Brain Res. 679(1), 42-48 https://doi.org/10.1016/0006-8993(95)00241-H
  19. Miyaji, H., S. Ito, T. Azuma, Y. Ito, Y. Yamazaki, Y. Ohtaki, F. Sato, M. Hirai, M. Kuriyama, and Y. Kohli (1997), Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis, Gut 40(6), 726-730 https://doi.org/10.1136/gut.40.6.726